• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
1,959 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

FAB

Fusion Antibodies
UK£0.0370%-89.0%UK£3.6mn/aPS2.3xn/an/a

ABLI

Abliva
kr0.160.6%-29.6%kr219.1mn/aPS1599.5xE-23.4%n/a

LCTX

Lineage Cell Therapeutics
US$1.11-7.5%-19.6%US$209.3mUS$5.20PS23.4xE53.0%n/a

PROK

ProKidney
US$2.7112.9%-72.3%US$621.5mUS$4.20PE-4.7xE-47.6%n/a

SAVA

Cassava Sciences
US$21.732.5%-4.1%US$939.7mUS$124.00PB6.8xE104.9%n/a

MEIP

MEI Pharma
US$3.10-4.6%-39.3%US$20.7mUS$23.00PE1xE-47.4%n/a

ATXS

Astria Therapeutics
US$9.17-13.0%-24.1%US$503.6mUS$25.29PB3.4xE28.2%n/a

TRVI

Trevi Therapeutics
US$2.54-5.4%-25.7%US$175.2mUS$7.40PB2.1xE-9.6%n/a

PASG

Passage Bio
US$1.221.7%18.4%US$75.2mUS$7.00PB0.7xE24.2%n/a

SGMT

Sagimet Biosciences
US$3.92-1.3%n/aUS$125.1mUS$42.00PS62.6xE-27.1%n/a

BBLG

Bone Biologics
US$1.52-15.3%-97.5%US$1.3mUS$19.50PB0.5xE0.5%n/a

CTX

Crescita Therapeutics
CA$0.43-1.1%-34.8%CA$8.4mn/aPB0.4xn/an/a

ALPN

Alpine Immune Sciences
US$64.620.3%792.5%US$4.2bUS$62.00PS72xE-13.6%n/a

XRTX

XORTX Therapeutics
CA$3.62-14.6%-52.7%CA$10.5mn/aPB1.7xE120.0%n/a

LTRN

Lantern Pharma
US$5.46-5.4%14.5%US$58.6mUS$22.00PB1.4xE-7.9%n/a

LENZ

LENZ Therapeutics
US$15.45-11.7%n/aUS$394.5mUS$36.75PE-5.6xE47.0%n/a

ARBS

Arterra Bioscience
€1.87-1.6%-25.2%€12.5mn/aPE12.7xn/a5.3%

FDMT

4D Molecular Therapeutics
US$23.53-5.0%42.6%US$1.2bUS$54.22PS58.1xE-1.9%n/a

BOLD

Boundless Bio
US$12.076.8%n/aUS$268.4mUS$23.00PE-5.4xE-21.1%n/a

MURA

Mural Oncology
US$3.53-1.1%n/aUS$59.7mUS$13.00PB0.2xn/an/a

TNYA

Tenaya Therapeutics
US$4.22-1.6%-13.5%US$331.3mUS$19.43PB2.4xE52.1%n/a

GHRS

GH Research
US$10.50-6.2%25.3%US$546.3mUS$31.75PB2.5xE-17.5%n/a

MGNX

MacroGenics
US$14.37-10.6%104.4%US$899.0mUS$24.78PS15.3xE-22.1%n/a

KOD

Kodiak Sciences
US$3.19-8.2%-30.6%US$166.8mUS$4.25PB0.6xE-8.2%n/a
Page 3 of 82
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.